Macquarie Group LTD Inspire Medical Systems, Inc. Transaction History

Macquarie Group LTD

$79.1 Billion
Q2 2025

A detailed history of Macquarie Group LTD transactions in Inspire Medical Systems, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 495,556 shares of INSP stock, worth $41.1 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

495,556

Previous 558,227 11.23%

Holding current value

$41.1 Million

Previous $88.9 Million 27.67%

% of portfolio

0.08%

Previous 0.11%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$127.18 - $161.88 $7.97 Million - $10.1 Million	-62,671 Reduced 11.23%	495,556 $64.3 Million
Q1 2025 May 15, 2025	BUY	$157.24 - $215.42 $3.24 Million - $4.44 Million	20,633 Added 3.84%	558,227 $88.9 Million
Q4 2024 Feb 14, 2025	SELL	$172.7 - $214.93 $7.72 Million - $9.61 Million	-44,726 Reduced 7.68%	537,594 $99.7 Million
Q3 2024 Nov 14, 2024	SELL	$125.79 - $216.71 $1.22 Million - $2.11 Million	-9,736 Reduced 1.64%	582,320 $123 Million
Q2 2024 Aug 09, 2024	BUY	$133.83 - $251.19 $4.49 Million - $8.43 Million	33,571 Added 6.01%	592,056 $79.2 Million
Q1 2024 May 14, 2024	BUY	$165.3 - $226.0 $3.29 Million - $4.5 Million	19,910 Added 3.7%	558,485 $120 Million
Q4 2023 Feb 14, 2024	SELL	$125.26 - $203.83 $8.15 Million - $13.3 Million	-65,031 Reduced 10.77%	538,575 $110 Million
Q3 2023 Nov 14, 2023	BUY	$185.0 - $326.08 $5.97 Million - $10.5 Million	32,279 Added 5.65%	603,606 $120 Million
Q2 2023 Aug 14, 2023	SELL	$226.52 - $324.64 $6.28 Million - $9.01 Million	-27,740 Reduced 4.63%	571,327 $185 Million
Q1 2023 May 15, 2023	SELL	$229.06 - $278.01 $106 Million - $128 Million	-461,605 Reduced 43.52%	599,067 $140 Million
Q4 2022 Feb 21, 2023	SELL	$164.02 - $259.76 $57 Million - $90.2 Million	-347,241 Reduced 24.66%	1,060,672 $267 Million
Q3 2022 Nov 14, 2022	SELL	$170.68 - $226.46 $22.6 Million - $30 Million	-132,582 Reduced 8.61%	1,407,913 $250 Million
Q2 2022 Aug 15, 2022	BUY	$147.53 - $266.6 $2.07 Million - $3.74 Million	14,017 Added 0.92%	1,540,495 $281 Million
Q1 2022 May 16, 2022	BUY	$193.94 - $261.91 $38.2 Million - $51.6 Million	196,945 Added 14.81%	1,526,478 $392 Million
Q4 2021 Feb 11, 2022	BUY	$207.57 - $280.17 $53.3 Million - $71.9 Million	256,762 Added 23.93%	1,329,533 $306 Million
Q3 2021 Nov 12, 2021	BUY	$170.0 - $258.58 $130 Million - $197 Million	762,866 Added 246.16%	1,072,771 $250 Million
Q2 2021 Aug 13, 2021	BUY	$164.93 - $242.23 $40 Million - $58.8 Million	242,689 Added 361.06%	309,905 $59.9 Million
Q1 2021 May 14, 2021	SELL	$182.45 - $249.25 $2.73 Million - $3.73 Million	-14,951 Reduced 18.2%	67,216 $13.9 Million
Q4 2020 Feb 16, 2021	SELL	$119.35 - $200.46 $2.1 Million - $3.52 Million	-17,569 Reduced 17.62%	82,167 $15.5 Million
Q3 2020 Nov 13, 2020	SELL	$87.5 - $130.91 $1.53 Million - $2.29 Million	-17,461 Reduced 14.9%	99,736 $12.9 Million
Q2 2020 Aug 11, 2020	SELL	$49.5 - $97.93 $840,807 - $1.66 Million	-16,986 Reduced 12.66%	117,197 $10.2 Million
Q1 2020 May 15, 2020	SELL	$41.62 - $89.92 $116,203 - $251,056	-2,792 Reduced 2.04%	134,183 $8.09 Million
Q4 2019 Feb 14, 2020	BUY	$52.12 - $75.0 $583,066 - $839,025	11,187 Added 8.89%	136,975 $10.2 Million
Q3 2019 Nov 14, 2019	SELL	$61.02 - $70.19 $15,438 - $17,758	-253 Reduced 0.2%	125,788 $7.68 Million
Q2 2019 Aug 14, 2019	BUY	$47.07 - $60.71 $2.17 Million - $2.79 Million	46,026 Added 57.52%	126,041 $7.64 Million
Q1 2019 May 15, 2019	BUY	$39.48 - $62.0 $1.97 Million - $3.1 Million	50,015 Added 166.72%	80,015 $4.54 Million
Q3 2018 Nov 15, 2018	BUY	$36.8 - $56.99 $1.1 Million - $1.71 Million	30,000 New	30,000 $1.26 Million

Others Institutions Holding INSP

# of Institutions

401

Shares Held

30.1M

Call Options Held

117K

Put Options Held

148K

View Full List

About Inspire Medical Systems, Inc.

Ticker INSP
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 28,788,600
Market Cap $2.39B
Description
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for m...

More about INSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Inspire Medical Systems, Inc. Transaction History